In experimentally induced allergic asthma, CAR-redirected Tregs suppressed allergic airway inflammation, prevented excessive pulmonary mucus production, and attenuated the increase of allergen-specific IgE and Th2 cytokine levels (144). The gene discussed is IGHE; the disease is allergic asthma.